Rapid Micro Biosystems, Inc.
RPID
$3.58
$0.102.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.21M | 8.22M | 7.60M | 6.62M | 5.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.21M | 8.22M | 7.60M | 6.62M | 5.61M |
| Cost of Revenue | 6.80M | 7.24M | 6.98M | 6.81M | 7.13M |
| Gross Profit | 404.00K | 981.00K | 622.00K | -189.00K | -1.52M |
| SG&A Expenses | 8.44M | 7.81M | 9.05M | 9.45M | 8.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.87M | 18.45M | 19.64M | 20.00M | 19.88M |
| Operating Income | -11.66M | -10.23M | -12.04M | -13.38M | -14.27M |
| Income Before Tax | -11.26M | -9.68M | -11.31M | -12.56M | -13.32M |
| Income Tax Expenses | 7.00K | -9.00K | 13.00K | 15.00K | 3.00K |
| Earnings from Continuing Operations | -11.26M | -9.67M | -11.32M | -12.58M | -13.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.26M | -9.67M | -11.32M | -12.58M | -13.32M |
| EBIT | -11.66M | -10.23M | -12.04M | -13.38M | -14.27M |
| EBITDA | -10.91M | -9.46M | -11.38M | -12.55M | -13.57M |
| EPS Basic | -0.26 | -0.22 | -0.26 | -0.29 | -0.31 |
| Normalized Basic EPS | -0.16 | -0.14 | -0.16 | -0.18 | -0.19 |
| EPS Diluted | -0.26 | -0.22 | -0.26 | -0.29 | -0.31 |
| Normalized Diluted EPS | -0.16 | -0.14 | -0.16 | -0.18 | -0.19 |
| Average Basic Shares Outstanding | 43.99M | 43.77M | 43.67M | 43.62M | 43.25M |
| Average Diluted Shares Outstanding | 43.99M | 43.77M | 43.67M | 43.62M | 43.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |